OncLive | Bringing the Global Oncology Community Together

Erlene Seymour, MD, discusses novel therapies as well as their potential applications in the treatment paradigm of chronic lymphocytic leukemia. Read More >>

Hurvitz Evaluates De-Escalation Strategies in Early-Stage HER2+ Breast Cancer

Expert Addresses Oncology Costs, Potential Impact of Biosimilars

FDA Approval Sought for Erdafitinib in Urothelial Carcinoma

Patient-Centered Focus Drives Growth at Virginia Urology

ITP Management Is Slowly Evolving With Novel Agents

View More Stories >>

View Conference Coverage

2018 International Liver Cancer Association Annual Conference

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

Dr. Bunn on the Treatment of Early-Stage Lung Cancer

Dr. Konecny on the Value of PARP Inhibitors in Ovarian Cancer

Dr. Sonpavde on Remaining Questions With Immunotherapy in Bladder Cancer

Dr. Ali on Adjuvant Studies With Biosimilars in Oncology

Dr. Eng Discusses the ADORE Trial in Rectal Cancer

Dr. Dent Discusses Ipatasertib in Triple-Negative Breast Cancer

Dr. Cohen Discusses the Treatment of MCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Emerging Combination Regimens in Advanced Melanoma

Best Practices in Molecular Profiling in NSCLC

Treatment of BRAF-Mutated Metastatic Colorectal Cancer

Second-Line PFS With Combination Biologics in mCRC

Recurrent Ovarian Cancer: PARP Inhibitors Compared

Significance of Next-Generation Sequencing in NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

TKI/I-O Therapy in mRCC

Therapeutic Sequencing in mRCC

Managing Patients on Lenvatinib/Everolimus in mRCC

Future of CDK4/6 Inhibition in HR+ Breast Cancer

$Lenvatinib and Everolimus in Relapsed/Refractory mRCC$

Abemaciclib Monotherapy's Role in HR+ Breast Cancer

Optimizing CDK4/6 Inhibition in HR+ Breast Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy

Over the past few decades, our knowledge of the role of gene mutations in oncogenesis has transformed cancer care.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

Priority Review in NSCLC, Label Update in CLL, Delayed FDA Decision in Lung Cancer, and More